(VIANEWS) – UCB (UCB.BR), WOLTERS KLUWER (WKL.AS), VOPAK (VPK.AS) are the highest payout ratio stocks on this list.
We have collected information concerning stocks with the highest payout ratio as yet. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. UCB (UCB.BR)
111.48% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €1.22.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 127.83. Meaning, the purchaser of the share is investing €127.83 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.67%.
More news about UCB.
2. WOLTERS KLUWER (WKL.AS)
46.45% Payout Ratio
Wolters Kluwer N.V. provides professional information, software solutions, and services in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally. The company operates through Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG segments. The Health segment offers clinical technology and evidence-based solutions that drive effective decision-making and improved outcomes across healthcare. It serves hospitals, healthcare organizations, clinicians, students, schools, libraries, payers, life sciences, and pharmacies. The Tax & Accounting segment offers solutions that help tax, accounting, and audit professionals to drive productivity, navigate change, and deliver better outcomes. It serves accounting firms, tax and auditing departments, businesses of all sizes, government agencies, libraries, and universities. The Financial & Corporate Compliance segment offers solutions for legal entity compliance and banking product compliance. It serves corporations, small businesses, law firms, banks, non-bank lenders, credit unions, insurers, and securities firms. The Legal & Regulatory segment provides information, insights, and workflow solutions for changing regulatory obligations, managing risk, and increasing efficiency. It provides solutions for legal and compliance professionals in law firms, corporate legal departments, universities, and government organizations. The Corporate Performance & ESG segment offers enterprise software to drive financial and sustainability performance and manage risks, meet reporting requirements, improve safety and productivity, and reduce environmental impact. It serves corporate finance, audit, planning, risk, environmental, health and safety, operational risk management, and sustainability professionals in corporations, banks, and governments. Wolters Kluwer N.V. was founded in 1836 and is based in Alphen aan den Rijn, the Netherlands.
Earnings Per Share
As for profitability, WOLTERS KLUWER has a trailing twelve months EPS of €4.29.
PE Ratio
WOLTERS KLUWER has a trailing twelve months price to earnings ratio of 34.76. Meaning, the purchaser of the share is investing €34.76 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.62%.
Moving Average
WOLTERS KLUWER’s worth is under its 50-day moving average of €149.18 and higher than its 200-day moving average of €137.02.
More news about WOLTERS KLUWER.
3. VOPAK (VPK.AS)
35.91% Payout Ratio
Koninklijke Vopak N.V., an independent tank storage company, stores and handles liquid chemicals, gases, and oil products to the energy and manufacturing markets worldwide. The company operates LPG and chemical gas, industrial, chemical, and oil terminals; and owns and operates specialized facilities consisting of tanks, jetties, truck loading stations, and pipelines. It stores and handles chemicals, such as methanol, xylenes, styrene, alpha olefins, and mono-ethylene glycol; gas, including LNG, LPG, ethylene, butadiene, and ammonia; oil products consisting of crude oil, fuel oil, diesel, jet fuel, gasoline, and naphtha; and vegoils and biofuels comprising ethanol, biodiesel, and sustainable aviation fuel. In addition, the company is involved in the development of infrastructure solutions within ports for low-carbon and renewable hydrogen, CO2, long-duration energy storage, and sustainable fuels and feedstocks. Further, it operates 76 terminals in 23 countries with a storage capacity of 35.2 million cubic meters. It serves producers, manufacturers, distributors, governments, traders, and chemical and energy companies. The company was founded in 1616 and is headquartered in Rotterdam, the Netherlands.
Earnings Per Share
As for profitability, VOPAK has a trailing twelve months EPS of €3.55.
PE Ratio
VOPAK has a trailing twelve months price to earnings ratio of 11.28. Meaning, the purchaser of the share is investing €11.28 for every euro of annual earnings.
Moving Average
VOPAK’s worth is above its 50-day moving average of €37.48 and way above its 200-day moving average of €33.46.
Volume
Today’s last reported volume for VOPAK is 28707 which is 80.6% below its average volume of 148003.
Yearly Top and Bottom Value
VOPAK’s stock is valued at €40.04 at 02:10 EST, above its 52-week high of €39.38.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 26, 2024, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 3.87%.
More news about VOPAK.
4. CRCAM NORM.SEINE (CCN.PA)
31.92% Payout Ratio
Caisse Régionale de Crédit Agricole Mutuel de Normandie-Seine Société coopérative offers various banking products and services to individuals, professionals, farmers, associations, and companies in France. It provides savings and securities accounts; real estate, personal, student, credit consolidation, work, housing transition, creation and installation, and vehicle loans; insurance products, including home, car and 2-wheeler, health, death, funeral, life accident, liability, legal protection, mobile, consumer credit and home borrower, association, employee, provident, and agricultural equipment and activity insurances. The company also offers debit and credit cards; mobile payment services; news and magazines; payment terminals; and funding products; as well as engages in real estate investment, and real estate and furniture leasing activities. The company was incorporated in 2000 and is headquartered in Bois-Guillaume, France.
Earnings Per Share
As for profitability, CRCAM NORM.SEINE has a trailing twelve months EPS of €13.51.
PE Ratio
CRCAM NORM.SEINE has a trailing twelve months price to earnings ratio of 5.33. Meaning, the purchaser of the share is investing €5.33 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.79%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 346.26M for the twelve trailing months.
More news about CRCAM NORM.SEINE.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
More news about 1.
